Inventor · disambiguated record
Yves Gareau
Also filed as: GAREAU YVES
17 granted patents·6 pending applications·408 citations·filing 1994–2023
94Inventor score
Files withUNIV MONTREAL6MERCK FROSST CANADA INC4MERCK FROSST CANADA LTD2AFFINIUM PHARM INC1BLOUIN MARC1
Top patents by PatentIndex Score
23 records- 0196US5532237AIndole derivatives with affinity for the cannabinoid receptorMERCK FROSST CANADA INC·Filed 1995·Granted Jul 2, 1996·223 cites·5 claims
- 0291US9409906B2Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cellsUNIV MONTREAL·Filed 2013·Granted Aug 9, 2016·22 cites·49 claims
- 0386US8901105B2Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamideAFFINIUM PHARM INC·Filed 2013·Granted Dec 2, 2014·8 cites·22 claims
- 0485US6242493B1Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatmentMERCK FROSST CANADA INC·Filed 1999·Granted Jun 5, 2001·41 cites·16 claims
- 0584US7960409B2Pharmaceutical phenylquinoline and chromen-2-one triazole compoundsMERCK SHARP & DOHME·Filed 2008·Granted Jun 14, 2011·8 cites·20 claims
- 0679US10035813B2Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamideDEBIOPHARM INT SA·Filed 2014·Granted Jul 31, 2018·3 cites·27 claims
- 0777US10647718B2Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cellsUNIV MONTREAL·Filed 2015·Granted May 12, 2020·3 cites·18 claims
- 0877US7553973B2Pharmaceutical compoundsMERCK FROSST CANADA LTD·Filed 2006·Granted Jun 30, 2009·3 cites·19 claims
- 0974US12286426B2Heterocyclic mitochondrial activity inhibitors and uses thereofUNIV MONTREAL·Filed 2023·Granted Apr 29, 2025·0 cites·19 claims
- 1069US6627656B2Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful thereforeFiled 2001·Granted Sep 30, 2003·5 cites·5 claims
- 1166US5834228AMethod for identifying inhibitors for apopain based upon the crystal structure of the apopain: Ac-DEVD-CHO complexMERCK & CO INC·Filed 1997·Granted Nov 10, 1998·38 cites·8 claims
- 1265US11760754B2Heterocyclic mitochondrial activity inhibitors and uses thereofUNIV MONTREAL·Filed 2018·Granted Sep 19, 2023·0 cites·6 claims
- 1365US5472964ADiaryl 5,6-fused heterocyclic acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1994·Granted Dec 5, 1995·20 cites·6 claims
- 1463US5798442APeptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinasesMERCK FROSST CANADA INC·Filed 1995·Granted Aug 25, 1998·25 cites·3 claims
- 1550US2009030048A1Novel pharmaceutical compoundsBLOUIN MARC·Filed 2008·Application pending·0 cites
- 1649US10336747B2Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cellsUNIV MONTREAL·Filed 2016·Granted Jul 2, 2019·0 cites·15 claims
- 1749US5750539AHeteroaryl diol acids as leukotriene antagonistsMERCK FROSST CANADA·Filed 1995·Granted May 12, 1998·9 cites·8 claims
- 1849US2010298347A1Substituted 2-naphthoic acids as antagonists of gpr105 activityMERCK FROSST CANADA LTD·Filed 2008·Application pending·0 cites
- 1947US2016222017A1Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cellsUNIV MONTREAL·Filed 2016·Application pending·0 cites
- 2044US7439260B27-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitorsMERCK FORSST CANADA & CO·Filed 2004·Granted Oct 21, 2008·0 cites·10 claims
- 2142US2013244929A1Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterialsGALLANT MICHEL·Filed 2011·Application pending·0 cites
- 2242US2010179173A1Substituted fused pyrimidines as antagonists of gpr105 activityGUAY DANIEL·Filed 2008·Application pending·0 cites
- 2332US2012010186A1Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseLACHANCE NICOLAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yves Gareau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →